Channel Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CHRO and buy or sell other stocks, ETFs, and their options commission-free!

About CHRO

Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil. 

CEO
Scott M. Plesha
CEOScott M. Plesha
Employees
92
Employees92
Headquarters
Durham, North Carolina
HeadquartersDurham, North Carolina
Founded
Founded
Employees
92
Employees92

CHRO Key Statistics

Market cap
43.66M
Market cap43.66M
Price-Earnings ratio
-1.20
Price-Earnings ratio-1.20
Dividend yield
Dividend yield
Average volume
18.49K
Average volume18.49K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$54.29
52 Week high$54.29
52 Week low
$9.00
52 Week low$9.00

Stock Snapshot

Channel Therapeutics(CHRO) stock is priced at $13.50, giving the company a market capitalization of 43.66M. It carries a P/E multiple of -1.20.

During the trading day, Channel Therapeutics(CHRO) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Channel Therapeutics(CHRO) stock has reached 0, versus its average volume of 18.49K.

The stock's 52-week range extends from a low of $9.00 to a high of $54.29.

The stock's 52-week range extends from a low of $9.00 to a high of $54.29.

People also own

Based on the portfolios of people who own CHRO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.